Chicago Children's Memorial Hosp

Chicago, Illinois 606143394

0 studies enrolling now · 33 studies all time

What they study most

Bacterial Infections, HIV Infections, HIV Seronegativity, Pneumonia, Pneumocystis Carinii, Pregnancy

Studies at this site

• The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children — Completed
• A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months — Completed
• The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS — Withdrawn before enrolling
• Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens — Completed
• Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs — Completed
• A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers — Completed
• A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children — Completed
• A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine — Completed
• A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children — Completed
• A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses — Completed
• A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants — Completed
• The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms — Completed
• A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV — Completed
• Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents — Completed
• A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia — Completed
• The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants — Completed
• A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment — Completed
• A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children — Completed
• A Study to Compare Two Different Anti-HIV Drug Regimens — Completed
• A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease — Completed
• A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies — Completed
• A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection — Completed
• Long-Term Effects of HIV Exposure and Infection in Children — Completed
• A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants — Completed
• Zidovudine and Lamivudine Given Once Versus Twice Daily — Completed
• Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV — Completed
• A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications — Completed
• A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children — Completed
• Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems — Completed
• A Blood Test to Look at Cells of the Immune System in Healthy Children — Completed
• A "Pre-Enrollment" Protocol for HIV-Infected Adolescents — Completed
• The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children — Completed
• A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection — Completed